"MedGuides" Required Only In Classes Where Patient Info Already Requested
Executive Summary
FDA will initially apply its MedGuide rule only to drug classes where the agency has already asked for patient-directed labeling, the agency said in its final rule "Prescription Drug Product Labeling; Medication Guide Requirements," published Dec. 1.
You may also be interested in...
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
FDA’s proposed new benchmark for incorporating a Medication Guide in a Risk Evaluation and Mitigation Strategy would reduce the regulatory burden on sponsors whose products do not warrant restricted distribution measures.
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
FDA’s proposed new benchmark for incorporating a Medication Guide in a Risk Evaluation and Mitigation Strategy would reduce the regulatory burden on sponsors whose products do not warrant restricted distribution measures.
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
"In most cases" a MedGuide would be included as part of a REMS only when elements to assure safe use are needed, the agency says in a draft guidance.